This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of complex organic molecules, particularly in the development of active pharmaceutical ingredients (APIs). Its unique spirocyclic structure and functional groups make it valuable for constructing biologically active compounds, especially those targeting neurological and metabolic disorders. The tert-butoxycarbonyl (Boc) protecting group allows for selective reactions during multi-step synthesis, while the difluoro and carboxylic acid groups enhance the molecule's reactivity and potential for further derivatization. It is often employed in medicinal chemistry research to explore new drug candidates with improved efficacy and safety profiles.